The Future of Antibiotics and Artificial Intelligence: Some Thoughts from Discovery to Bedside

Antibiotic discovery and antibiotic prescribing represent two domains that both stand to benefit from artificial intelligence (AI)-driven progress in the near future. In this article, we discuss these parallel advances and the potential future synergy between AI-enabled antibiotic discovery and AI-assisted antibiotic prescribing. Although multiple challenges remain before these two domains meaningfully converge, their integration could amplify the strengths of each: discovery pipelines generating broader, more diverse classes of antibacterial agents, and prescribing tools capable of matching these agents to individual patients with unprecedented precision. Such a scenario could transform antibiotic therapy by enabling AI-supported, patient-specific treatment decisions while reinforcing the principles of precision medicine and antimicrobial stewardship.

Authors

Institutions

Publication Details

Journal
Infectious Diseases and Therapy
Published
2025-12-24
DOI
https://doi.org/10.1007/s40121-025-01288-y
Citations
1
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Future of Antibiotics and Artificial Intelligence: Some Thoughts from Discovery to Bedside

Daniele Roberto Giacobbe, Cesar de la Fuente-Nunez, Alessandra Agnese Grossi, Matteo Bassetti
1 citations
Infectious Diseases and Therapy
Artificial Intelligence in Healthcare and Education
0.65
article

The Future of Antibiotics and Artificial Intelligence: Some Thoughts from Discovery to Bedside

Daniele Roberto Giacobbe, Cesar de la Fuente-Nunez, Alessandra Agnese Grossi, Matteo Bassetti
article en
1 citations

Abstract

Antibiotic discovery and antibiotic prescribing represent two domains that both stand to benefit from artificial intelligence (AI)-driven progress in the near future. In this article, we discuss these parallel advances and the potential future synergy between AI-enabled antibiotic discovery and AI-assisted antibiotic prescribing. Although multiple challenges remain before these two domains meaningfully converge, their integration could amplify the strengths of each: discovery pipelines generating broader, more diverse classes of antibacterial agents, and prescribing tools capable of matching these agents to individual patients with unprecedented precision. Such a scenario could transform antibiotic therapy by enabling AI-supported, patient-specific treatment decisions while reinforcing the principles of precision medicine and antimicrobial stewardship.

Infectious Diseases and TherapyVol. 15(2)
University of Insubria (IT), University City Science Center (US), University of the Arts (US), Translational Therapeutics (United States) (US), Ospedale Policlinico San Martino (IT), University of Pennsylvania (US), University of Genoa (IT), Philadelphia University (US)
Openalex Percentile: Top 18%
Artificial Intelligence in Healthcare and Education
0.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.